Skip to main content

Our funding in numbers.

The Boehringer Ingelheim Foundation fulfils its statutory purpose by funding excellent basic research in medicine, biology, chemistry, and pharmacy. Its funding focus lies on the University of Mainz.

The foundation’s Germany-wide Plus 3 and Exploration Grants programmes offer outstanding and independent junior group leaders the freedom necessary to realise their scientific potential and to test new ideas. The foundation also supports scientific conferences around the world, with the particular aim of promoting dialogue between different generations of scientists.

The foundation awards the internationally renowned Heinrich Wieland Prize to honour distinguished scientists from around the world for their ground-breaking research.It also endows awards for excellent junior researchers, namely the Boehringer Ingelheim Prize and four PhD student prizes at the University of Mainz.

As a recognised charitable organisation, the Boehringer Ingelheim Foundation is not subject to corporate and trade taxes (current notice of tax exemption issued by the Bingen-Alzey tax office on 12 December 2022, for 2018 to 2020, tax ID number 08/667/10470). The annual financial statement of the Boehringer Ingelheim Foundation is audited by Rödl & Partner GmbH Wirtschaftsprüfungsgesellschaft Steuerberatungsgesellschaft based on the Generally Accepted Standards for the Review of Financial Statements (IDW AuS 900).

Expenditures of the Boehringer Ingelheim Foundation in 2022

In 2022, the Boehringer Ingelheim Foundation spent some 16.8 million euros on the promotion of science. Its administration costs amounted to about 814 TEUR.